Abstract:Poor aqueous solubility of crystalline active pharmaceutical ingredients (API) restricts their bioavailability. Amorphous solid dispersions with biocompatible polymer excipients offers a solution to overcome this problem, potentially enabling a broader use of many drug candidate molecules. This work addresses various aspects of in silico design of a suitable combination of an API and a polymer to form such a binary solid dispersion. Molecular interactions in such bulk systems are tracked at full atomic resolution within molecular-dynamics (MD) simulations, enabling to identify API – polymer pairs that exhibit the most beneficial interactions. Importance of those interactions is manifold: increasing the mutual miscibility, kinetic stabilization of their amorphous dispersions and impedance of the spurious recrystallization of the API component. MD tools are used to investigate the structural and cohesive properties of pure compounds and mixtures, with a special emphasis on molecular interactions, microscopic structure and internal dynamics. This analysis is then accompanied by a macroscopic image of the energetic compatibility and vitrification tendency of the mixtures in terms of their excess enthalpies and glass transition temperatures. Density-functional theory (DFT) and non-covalent interaction (NCI) analysis fortify our computational conclusions and enable us to map intensities of particular NCI among the individual target materials and relevant molecular sites therein. Three archetypal polymer excipients and four API molecules are included in this study. Results of our computational analysis of molecular interactions in bulk systems agree with the experimentally observed trends of solubility of the given API in polymers. Our calculations confirm PVP as the most potent acceptor of hydrogen bonding among the considered polymer excipients, whereas ibuprofen molecules are predicted to be the most efficient hydrogen bond donors among our target API. Our simulations also suggest that carbamazepine does not exhibit particularly strong interactions with the considered polymer excipients. Although current MD cannot offer quantitative accuracy of many of the discussed descriptors, current computational models focusing on NCI of API with polymer excipients contributes to understanding of the behavior of these materials at the molecular level, and thus also to the rational design of novel efficient drug formulations.

Study the solubility of pharmaceutical ingredients and their eutectic mixtures: An in-depth density functional theory and molecular dynamics simulations approaches

Eutectic Mixtures of APIs: A way to Improve the Physiochemical Properties and Oral Bioavailability of the Drugs

A brief review on eutectic mixture and its role in pharmaceutical field

Molecular Insights on Kinetic Stabilization of Amorphous Solid Dispersion of Pharmaceuticals

Deep Eutectic Solvents Enhancing Drug Solubility and Its Delivery

Solids Turn into Liquids—Liquid Eutectic Systems of Pharmaceutics to Improve Drug Solubility

Development of deep eutectic solvent systems and their formulation: Assessment of solubilization potential on poorly water-soluble drugs.

Exploring Deep Eutectic Solvents as Pharmaceutical Excipients: Enhancing the Solubility of Ibuprofen and Mefenamic Acid

Overview and thermodynamic modelling of deep eutectic solvents as co-solvents to enhance drug solubilities in water

Amorphous Solid Dispersions: Implication of Method of Preparation and Physicochemical Properties of API and Excipients

Experimental and Theoretical Insights into the Intermolecular Interactions in Saturated Systems of Dapsone in Conventional and Deep Eutectic Solvents

Analytical and Computational Methods for the Determination of Drug-Polymer Solubility and Miscibility

Solubility Enhancement of Poorly Water-Soluble Drugs by Solid Dispersion Techniques

Experimental and Machine-Learning-Assisted Design of Pharmaceutically Acceptable Deep Eutectic Solvents for the Solubility Improvement of Non-Selective COX Inhibitors Ibuprofen and Ketoprofen

Design of Ternary Amorphous Solid Dispersions for Enhanced Dissolution of Drug Combinations

Controlled release of pharmaceutical agents using eutectic modified gelatin

Designing type V deep eutectic solvents with antimalarial pharmaceutical ingredients

Predicting the Solubility Advantage of Amorphous Pharmaceuticals: A Novel Thermodynamic Approach.

Molecular Dynamics Simulation of Drug Solubilization Behavior in Surfactant and Cosolvent Injections

Navigating the Solution to Drug Formulation Problems at Research and Development Stages by Amorphous Solid Dispersion Technology

Molecular insights into the aggregation and solubilizing behavior of biocompatible amphiphiles Gelucire® 48/16 and Tetronics® 1304 in aqueous media